Search All UT System Experts

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Fevzi F. Yalniz, Jesus G. Berdeja, Michael B. Maris, Roger M. Lyons, James A. Reeves, James H. Essell, Prapti Patel, Mikkael Sekeres, Amanda Hughes, Silvia Mappa, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences